Publikationen in Zusammenarbeit mit Forschern von Imperial College London (5)

2019

  1. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628

2018

  1. Alirocumab and cardiovascular outcomes after acute coronary syndrome

    New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107

2012

  1. Immediate and late benefits of treating very elderly people with hypertension: Results from active treatment extension to hypertension in the very elderly randomised controlled trial

    BMJ (Online), Vol. 344, Núm. 7839

2010

  1. The effect of treatment based on a diuretic (indapamide) ± ACE inhibitor (perindopril) on fractures in the hypertension in the very elderly trial (HYVET)

    Age and Ageing, Vol. 39, Núm. 5, pp. 609-616

2003

  1. Results of the pilot study for the Hypertension in the Very Elderly Trial

    Journal of Hypertension, Vol. 21, Núm. 12, pp. 2409-2417